TWD 65.1
(-0.61%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 1.53 Billion TWD | -17.57% |
2022 | 1.86 Billion TWD | 2.13% |
2021 | 1.82 Billion TWD | 0.85% |
2020 | 1.81 Billion TWD | -6.15% |
2019 | 1.93 Billion TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 124.35 Million TWD | 0.0% |
2024 Q1 | 124.35 Million TWD | -65.7% |
2023 Q3 | 362.51 Million TWD | -10.86% |
2023 FY | 1.53 Billion TWD | -17.57% |
2023 Q2 | 406.66 Million TWD | 0.0% |
2023 Q1 | 406.66 Million TWD | -14.09% |
2023 Q4 | 362.51 Million TWD | 0.0% |
2022 FY | 1.86 Billion TWD | 2.13% |
2022 Q4 | 473.33 Million TWD | 0.0% |
2022 Q3 | 473.33 Million TWD | 0.0% |
2021 FY | 1.82 Billion TWD | 0.85% |
2020 FY | 1.81 Billion TWD | -6.15% |
2019 FY | 1.93 Billion TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Allied Biotech Corporation | 720.43 Million TWD | -113.532% |
GeneFerm Biotechnology Co., Ltd. | 793.77 Million TWD | -93.803% |
Easywell Biomedicals, Inc. | 271.62 Million TWD | -466.345% |
TTY Biopharm Company Limited | 5.5 Billion TWD | 72.058% |
Synmosa Biopharma Corporation | 5.14 Billion TWD | 70.074% |
Orient EuroPharma Co., Ltd. | 4.59 Billion TWD | 66.499% |
Center Laboratories, Inc. | 1.39 Billion TWD | -10.355% |
Tien Liang BioTech Co., Ltd. | 459.99 Million TWD | -234.429% |
Orient Pharma Co., Ltd. | 889.91 Million TWD | -72.866% |
InnoPharmax Inc. | 46.07 Million TWD | -3238.945% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 606.71 Million TWD | -153.556% |
Excelsior Biopharma Inc. | 771.56 Million TWD | -99.382% |
Foresee Pharmaceuticals Co., Ltd. | 195.03 Million TWD | -688.745% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | -39.051% |
UniPharma Co., Ltd. | 103.22 Million TWD | -1390.333% |
Anxo Pharmaceutical Co., Ltd. | 939.94 Million TWD | -63.664% |
Alar Pharmaceuticals Inc. | 469.27 Million TWD | -227.817% |
Winston Medical Supply Co., Ltd. | 709.07 Million TWD | -116.952% |
Mercury Biopharmaceutical Corporation | 1.03 Million TWD | -148820.813% |
Bioray Biotech Co., Ltd | 191.83 Million TWD | -701.935% |
TSH Biopharm Corporation Limited | 810.91 Million TWD | -89.705% |